0001782348-25-000003.txt : 20251031 0001782348-25-000003.hdr.sgml : 20251031 20251031131311 ACCESSION NUMBER: 0001782348-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251031 DATE AS OF CHANGE: 20251031 EFFECTIVENESS DATE: 20251031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alume Biosciences Inc CENTRAL INDEX KEY: 0001782348 ORGANIZATION NAME: EIN: 822094372 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-562705 FILM NUMBER: 251439570 BUSINESS ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 205 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-254-7116 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 205 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001782348 Alume Biosciences Inc 2223 AVENIDA DE LA PLAYA SUITE 205 LA JOLLA CA CALIFORNIA 92037 858-254-7116 DELAWARE None None Corporation true Quyen Nguyen 2223 Avenida de La Playa Suite 205 La Jolla CA CALIFORNIA 92037 Executive Officer Director Brett Berman 2223 Avenida de La Playa Suite 205 La Jolla CA CALIFORNIA 92037 Executive Officer Director Dan Bradbury 2223 Avenida de La Playa Suite 205 La Jolla CA CALIFORNIA 92037 Director Kim Kamdar 2223 Avenida de La Playa Suite 205 La Jolla CA CALIFORNIA 92037 Director Magda Marquet 2223 Avenida de La Playa Suite 205 La Jolla CA CALIFORNIA 92037 Director Jean-Pierre Millon 2223 Avenida de La Playa Suite 205 La Jolla CA CALIFORNIA 92037 Director James Schmidt 2223 Avenida de La Playa Suite 205 La Jolla CA CALIFORNIA 92037 Executive Officer Kaveri Parker 2223 Avenida de La Playa Suite 205 La Jolla CA CALIFORNIA 92037 Executive Officer Biotechnology Decline to Disclose 06b false 2025-10-30 false true false 25000 PHX Financial Inc. 144403 None None 100 Wall Street 10th Floor New York NY NEW YORK 10005 AZ ARIZONA CA CALIFORNIA CO COLORADO FL FLORIDA MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OR OREGON TX TEXAS VA VIRGINIA WA WASHINGTON false 23499998 3055500 20444498 false 37 299065 true 0 The stated commission amount consists of commissions of approximately 77% of such amount and reimbursement of expenses of approximately 23% of such amount. 0 false Alume Biosciences Inc James Schmidt James Schmidt Chief Financial Officer 2025-10-30